Log in to save to my catalogue

Recombinant ADAMTS13 for Immune Thrombotic Thrombocytopenic Purpura

Recombinant ADAMTS13 for Immune Thrombotic Thrombocytopenic Purpura

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_3084766655

Recombinant ADAMTS13 for Immune Thrombotic Thrombocytopenic Purpura

About this item

Full title

Recombinant ADAMTS13 for Immune Thrombotic Thrombocytopenic Purpura

Publisher

United States: Massachusetts Medical Society

Journal title

The New England journal of medicine, 2024-07, Vol.391 (4), p.382-384

Language

English

Formats

Publication information

Publisher

United States: Massachusetts Medical Society

More information

Scope and Contents

Contents

To the Editor:
In their Brief Report on the use of recombinant human ADAMTS13 (rADAMTS13) in a patient with refractory immune thrombotic thrombocytopenic purpura (iTTP) with a complicated course, Bendapudi et al. (May 9 issue)
1
describe the upfront use of an experimental treatment (bortezomib and intravenous immune globulin) rather than a...

Alternative Titles

Full title

Recombinant ADAMTS13 for Immune Thrombotic Thrombocytopenic Purpura

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_3084766655

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_3084766655

Other Identifiers

ISSN

0028-4793,1533-4406

E-ISSN

1533-4406

DOI

10.1056/NEJMc2406975

How to access this item